Aug 27 (Reuters) - Pfizer Inc (PFE.N), opens new tab is launching a new website to promote and improve access to its health care offerings for migraine and respiratory illnesses. The drugmaker ...
Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield-- the highest among major drug manufacturers and one of the ...
Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Cutting out middleman and selling drugs straight to patients. The company launched ...
Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Using telehealth to sell drugs straight to patients. The company launched a website ...
NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi ...
In a report released today, Akash Tewari from Jefferies assigned a Buy rating to Pfizer (PFE – Research Report), with a price target of $35.00. The company’s shares closed yesterday at $30.07.
To start, according to Pfizer’s launch announcement Tuesday, the platform’s services will focus on providing access to treatments for common conditions like migraine, COVID-19 and the flu as ...
The Food and Drug Administration has greenlighted three updated vaccines — the Pfizer-BioNTech and Moderna shots, and now a third one from Novavax, which was just authorized by the FDA on Friday.
The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna ... and syringes with the ... [+] logo of US biotech company Novavax.
Pfizer and Valneva may have about two more years to wait before they make the first approval filing to the FDA for a Lyme disease vaccine, but that hasn’t stopped the companies collecting more ...
Pfizer Inc. (PFE) said Saturday that its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation ...
A healthcare provider gives a patient a Covid shot. The FDA approved new COVID-19 vaccines from Pfizer and Moderna on Thursday ahead of the 2024-2025 fall and winter respiratory virus season ...